Stefanis L - Search Results

1

Targeting intracellular and extracellular alpha-synuclein as a therapeutic strategy in Parkinson's disease and other synucleinopathies.

Vekrellis K, Stefanis L. Vekrellis K, et al. Among authors: stefanis l. Expert Opin Ther Targets. 2012 Apr;16(4):421-32. doi: 10.1517/14728222.2012.674111. Expert Opin Ther Targets. 2012. PMID: 22480256 Review.

2

RAIDD aggregation facilitates apoptotic death of PC12 cells and sympathetic neurons.

Jabado O, Wang Q, Rideout HJ, Yeasmin M, Guo KX, Vekrellis K, Papantonis S, Angelastro JM, Troy CM, Stefanis L. Jabado O, et al. Among authors: stefanis l. Cell Death Differ. 2004 Jun;11(6):618-30. doi: 10.1038/sj.cdd.4401397. Cell Death Differ. 2004. PMID: 14765136

3

Neurobiology of alpha-synuclein.

Vekrellis K, Rideout HJ, Stefanis L. Vekrellis K, et al. Among authors: stefanis l. Mol Neurobiol. 2004 Aug;30(1):1-21. doi: 10.1385/MN:30:1:001. Mol Neurobiol. 2004. PMID: 15247485 Review.

4

Apoptosis and the conformational change of Bax induced by proteasomal inhibition of PC12 cells are inhibited by bcl-xL and bcl-2.

Lang-Rollin I, Maniati M, Jabado O, Vekrellis K, Papantonis S, Rideout HJ, Stefanis L. Lang-Rollin I, et al. Among authors: stefanis l. Apoptosis. 2005 Aug;10(4):809-20. doi: 10.1007/s10495-005-0378-5. Apoptosis. 2005. PMID: 16133871

5

A novel pathway for transcriptional regulation of alpha-synuclein.

Clough RL, Stefanis L. Clough RL, et al. Among authors: stefanis l. FASEB J. 2007 Feb;21(2):596-607. doi: 10.1096/fj.06-7111com. Epub 2006 Dec 13. FASEB J. 2007. PMID: 17167067

6

A novel cell death pathway that is partially caspase dependent, but morphologically non-apoptotic, elicited by proteasomal inhibition of rat sympathetic neurons.

Lang-Rollin I, Dermentzaki G, Vekrellis K, Xilouri M, Rideout HJ, Stefanis L. Lang-Rollin I, et al. Among authors: stefanis l. J Neurochem. 2008 May;105(3):653-65. doi: 10.1111/j.1471-4159.2007.05165.x. Epub 2008 Jan 8. J Neurochem. 2008. PMID: 18194212 Free article.

7

Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells.

Vogiatzi T, Xilouri M, Vekrellis K, Stefanis L. Vogiatzi T, et al. Among authors: stefanis l. J Biol Chem. 2008 Aug 29;283(35):23542-56. doi: 10.1074/jbc.M801992200. Epub 2008 Jun 19. J Biol Chem. 2008. PMID: 18566453 Free PMC article.

8

alpha-synuclein degradation by autophagic pathways: a potential key to Parkinson's disease pathogenesis.

Xilouri M, Vogiatzi T, Vekrellis K, Stefanis L. Xilouri M, et al. Among authors: stefanis l. Autophagy. 2008 Oct;4(7):917-9. doi: 10.4161/auto.6685. Epub 2008 Oct 26. Autophagy. 2008. PMID: 18708765

9

Cell-produced alpha-synuclein oligomers are targeted to, and impair, the 26S proteasome.

Emmanouilidou E, Stefanis L, Vekrellis K. Emmanouilidou E, et al. Among authors: stefanis l. Neurobiol Aging. 2010 Jun;31(6):953-68. doi: 10.1016/j.neurobiolaging.2008.07.008. Epub 2008 Aug 20. Neurobiol Aging. 2010. PMID: 18715677

10

Selective noradrenergic vulnerability in α-synuclein transgenic mice.

Sotiriou E, Vassilatis DK, Vila M, Stefanis L. Sotiriou E, et al. Among authors: stefanis l. Neurobiol Aging. 2010 Dec;31(12):2103-14. doi: 10.1016/j.neurobiolaging.2008.11.010. Epub 2009 Jan 18. Neurobiol Aging. 2010. PMID: 19152986

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

345 results

Search Page

Filters